Reinterpretation Of Genomic Test Results For Children With Epilepsy May Lead To Clinically Significant Changes, Study Indicates.

MD Magazine (2/12, Lutz) reports researchers “retrospectively reviewed 309 pediatric epilepsy screenings in order to examine the value of reinterpreting previously reported genomic test results,” and reclassified variants in “about a third of patients,” w...